$KTCC

KEY TRONIC CORP (KTCC): Results of Operations and Financial Condition

KEY TRONIC CORP (KTCC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE CONTACTS: Tony Voorhees Michael Newman Chief Financial Officer Investor Relations Key Tronic Corporation StreetConnect (509)-927-5345 (206) 729-3625 KEY TRONIC CORPORATION ANNOUNCES RESULTS FOR THE FOURTH QUARTER AND YEAR END OF FISCAL 2026 Stro

Original reporting
Published Aug 27, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$KTCC
Bearish
medium confidence
Mentioned
$KTCC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KTCCBearishMed
01

Why it matters

The earnings release shows a revenue decline YoY, widening net loss, but modest gross margin expansion and strategic restructuring, which may drive short‑term volatility.

02

Market read

First‑hand earnings data for a small‑cap EMS firm; provides fresh insight into sector trends and company‑specific operational changes.

03

What to watch

Potential upside from $60M new program awards and cost savings from China wind‑down not fully priced yet.

Relevance 7/10Novelty 7/10Timing: released after market on Aug 27, 2026

Background

Key Tronic Corp (Nasdaq: KTCC) is an electronic manufacturing services provider reporting its Q4 and FY2026 financials via an SEC 8‑K filing.

Company-level read

Ticker impact

$KTCCBearishMedium confidence
Context

Key Tronic Corp disclosed Q4 and FY2026 results, including revenue, margins, net loss and operational updates.

Expected impact

Potential short‑term downside pressure due to net loss, with upside if margin improvements accelerate.

Evidence & confidence

Losses are larger than prior year, but margin expansion and cost cuts could support a rebound; market reaction likely mixed.

Market effects

Highlights ongoing challenges and restructuring in the EMS sector, may affect peers' valuations.

U.S. and Vietnam manufacturing sites gain focus; China exit could influence regional supply‑chain dynamics.

Reflects broader macro‑economic credit constraints impacting EMS providers worldwide.

Counterpoint

Margin improvements and new program wins could outweigh the reported loss, suggesting a buying opportunity.

Key entities

  • Key Tronic Corp

    Electronic manufacturing services provider.

  • Brett Larsen

    President and CEO of Key Tronic Corp.

Related articles

Med

Key Tronic Corporation Q4 2026 Earnings Call Summary

Key Tronic Corporation reported Q4 2026 earnings impacted by $28.4M non-cash valuation allowance and $8.4M receivables write-off. Revenue rose 14% sequentially, driven by Vietnam demand. Management shifted production from China to U.S. and Vietnam, improving margins to 8.3%. The company expects revenue growth and profitability in fiscal 2027, supported by a $60M new program award. Liquidity constraints and supply chain pressures were noted.

$KTCCMed

Key Tronic Corporation Announces Results for the Fourth Quarter and Year End of Fiscal 2026 · EMSNow

Key Tronic Corporation (KTCC) reported Q4 2026 revenue of $102.0M, up 14% sequentially, driven by strong demand. Full-year revenue was $386.7M, down from $467.9M in 2025. Gross margin improved to 7.8% from 6.2%. The company faced supply chain constraints and reported a net loss of $34.3M for the quarter. Management highlighted new program wins and cost-cutting initiatives.

$AZOMedAI 8/10

AutoZone Q4 EPS Hits $56.05 as Annual Sales Reach $20.3bn

AutoZone (AZO) reported Q4 2026 EPS of $56.05, up from $48.71 a year earlier, with net sales of $6.6bn, a 5.6% increase. Full-year sales reached $20.3bn, up 7.4%. Gross margin rose to 53.3%, boosted by tariff refunds and LIFO benefits. The company opened 175 new stores, ending the year with 8,031 locations. Shares rose 4.33% post-earnings.

$AZOHighAI 8/10

Why AutoZone (AZO) Stock Is Trading Up Today

AutoZone (AZO) shares rose 6.1% after reporting Q4 EPS of $56.05, beating estimates. Net sales were $6.6B, missing expectations. Same-store sales grew 1.6%, and gross margin expanded 182 bps to 53.3%. The company's stock has had limited volatility, with today's move being notable. AZO is down 9.9% YTD, trading 30.6% below its 52-week high.

$AMGNMedAI 8/10

Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data - Amgen (NA

Amgen (AMGN) reported positive results from its Phase 3 OASIZ 301 trial for dazodalibep in treating Sjögren’s disease, meeting the primary endpoint. The study showed statistically significant improvements in disease activity scores. Adverse events were low and similar to placebo. Amgen plans to share full data at a future conference and awaits results from another trial, OASIZ 303, for potential FDA filing. Shares rose 3.54% to $407.08. Analysts expect two positive trials for approval.